QuidelOrtho Inc. (QDEL) Price to Earnings Ratio

Diversification of infection and cardiac tests reduces seasonal risks for QuidelOrtho (QDEL), as clearly demonstrated by the company's P/E time series, where the current parameter stands at -2.20. Long-term contracts for analyzer consumables ensure stability. However, the post-pandemic decline in demand for rapid diagnostics has increased unit costs, necessitating a deep restructuring of the operating model to restore profitability.

The P/E ratio determines the payback period of an asset's market value based on generated net profit, allowing an investor to identify whether an issuer is undervalued or overvalued relative to the sector. By analyzing the earnings multiple of QuidelOrtho (QDEL), one can assess the extent to which the market is willing to award a premium to the "razor and blade" model of QuidelOrtho, where capital-intensive analyzer installations ensure a steady stream of high-margin revenue from the sale of consumables.